Edition:
United States

Oramed Pharmaceuticals Inc (ORMP.OQ)

ORMP.OQ on NASDAQ Stock Exchange Capital Market

4.74USD
18 Sep 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.74
Open
$4.75
Day's High
$4.75
Day's Low
$4.75
Volume
143
Avg. Vol
9,187
52-wk High
$11.34
52-wk Low
$4.61

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 May '18 0.62 -0.300
Feb '18 0.60 -0.202
Nov 0.61 -0.178
FY 2017 Aug '17 0.62 -0.200
May '17 0.62 -0.148
Feb '17 0.61 -0.240
Nov 0.61 -0.200
FY 2016 Aug '16 0.35 -0.362
May '16 0.16 -0.152
Feb '16 0.12 -0.144
Nov 0.00 -0.207
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending May-18 2 0.61 0.62 0.60 --
Quarter Ending Aug-18 1 0.62 0.62 0.62 --
Year Ending Aug-18 1 2.45 2.45 2.45 2.80
Year Ending Aug-19 1 6.47 6.47 6.47 --
Earnings (per share)
Quarter Ending May-18 2 -0.29 -0.27 -0.31 --
Quarter Ending Aug-18 1 -0.29 -0.29 -0.29 --
Year Ending Aug-18 1 -0.98 -0.98 -0.98 -1.27
Year Ending Aug-19 1 -1.24 -1.24 -1.24 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 108.51 32.45
P/E High - Last 5 Yrs. -- 279.56 47.46
P/E Low - Last 5 Yrs. -- 98.19 24.76
Beta 0.46 0.62 0.87
Price to Sales (TTM) 33.73 109.91 6.31
Price to Book (MRQ) 4.13 12.50 3.81
Price to Tangible Book (MRQ) 4.96 18.78 5.83
Price to Cash Flow (TTM) -- 62.06 23.35
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.73
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.59 -5.47
Payout Ratio(TTM) -- 5.87 46.56

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 0.00 176.70 8.47
Sales (TTM) vs TTM 1 Yr. Ago 11.82 93.28 6.75
Sales - 5 Yr. Growth Rate -- 24.52 7.58
EPS (MRQ) vs Qtr. 1 Yr. Ago -103.00 278.78 25.58
EPS (TTM) vs TTM 1 Yr. Ago 7.29 -- --
EPS - 5 Yr. Growth Rate -- 23.69 7.60
Capital Spending - 5 Yr. Growth Rate 26.87 38.72 8.44

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.19
Current Ratio (MRQ) 4.18 5.46 2.96
LT Debt to Equity (MRQ) 0.00 14.93 11.41
Total Debt to Equity (MRQ) 0.00 18.35 14.25
Interest Coverage (TTM) -- -202.84 35.04

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 103.51 55.99 54.86
Gross Margin - 5 Yr. Avg. -- 52.63 53.37
EBITD Margin (TTM) -539.80 -- --
EBITD - 5 Yr. Avg -1,238.28 -174.66 15.90
Operating Margin (TTM) -540.00 -602.22 3.68
Operating Margin - 5 Yr. Avg. -1,239.07 -188.17 10.98
Pre-Tax Margin (TTM) -510.08 -599.02 3.98
Pre-Tax Margin - 5 Yr. Avg. -1,196.99 -190.53 11.16
Net Profit Margin (TTM) -510.08 -594.39 0.72
Net Profit Margin - 5 Yr. Avg. -1,246.49 -188.29 7.49
Effective Tax Rate (TTM) -- 11.59 20.36
Effective Tax Rate - 5 Yr. Avg. -- 19.14 24.27

Efficiency

  Company industry sector
Revenue/Employee (TTM) 175,000 5,161,374 703,739,345
Net Income/Employee (TTM) -892,643 -5,875,094 81,128,873
Receivable Turnover (TTM) -- 5.34 5.02
Inventory Turnover (TTM) -- 2.04 3.61
Asset Turnover (TTM) 0.07 0.38 0.81

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -33.57 0.84 9.67
Return on Assets - 5 Yr. Avg. -31.73 2.59 10.83
Return on Investment (TTM) -39.19 1.61 12.63
Return on Investment - 5 Yr. Avg. -34.42 2.06 13.94
Return on Equity (TTM) -68.54 0.35 14.80
Return on Equity - 5 Yr. Avg. -42.21 -2.36 15.32
  1 Year 3 Year 5 Year
Sales % 283.15 -- --
EPS (TTM) % 9.33 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Oramed Pharmaceuticals Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 25.38%
# of Holders: 33
Total Shares Held: 4,406,766
3 Mo. Net Change: 2,776,168
# New Positions: 7
# Closed Positions: 3
# Increased Positions: 10
# Reduced Positions: 7
# Net Buyers: 3
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.